Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

{{facet.display}}

{{facet.count}}

{{facet.count}}

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for succimer in Mixture Component Name (approximate match)

Showing 1 - 1 of 1 results

First page disabled
Previous page disabled
1
Next page disabled
Next page disabled

2,3-DIMERCAPTOSUCCINIC ACID

4S9JU7XF01

Status:

Possibly Marketed Outside US

Source:

Rotop - Dmsa by ROTOP Pharmaka GmbH

Source URL:

https://www.drugbank.ca/drugs/DB14089

First approved in 2012

Source:

Unapproved drug other

Source URL:

https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=5b11e596-3044-429b-9e48-33ba00946151

Class:

MIXTURE

Mixture

2,3-DIMERCAPTOSUCCINIC ACID

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1